Kelyniam Global Releases Q1 Financials
CANTON, Conn., May 13, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its quarter ended March 31, 2024.
- CANTON, Conn., May 13, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its quarter ended March 31, 2024.
- Chief Operating and Revenue Officer, Desiree Webb, said, "Sales momentum from Q4 continued into Q1, resulting in record growth, quarterly revenue and profit.
- Surgeons and Distributors using Kelyniam custom cranial and craniofacial implants have increased, in addition to the level of case complexity.
- Kelyniam Inc., specializes in the rapid production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers.